Interested to attend a conference with the goal of creating a momentum to minimize the disparities in cancer care ?
Here is a wonderful opportunity !
Save the Dates !
The Binaytara Foundation (BTF) conducting the 2019 Summit on National & Global Cancer Health Disparities (SCHD19)
The Binaytara Foundation (BTF) is a 501(c)3 non profit established in 2007 with the goal of promoting health and education in resource poor communities. BTF has a special consultative status with the United Nations Economic and Social Council (ECOSOC).
The Binaytara Foundation aims to improve healthcare in resource-poor communities and improve cancer care worldwide by collaborating with other organizations, individuals, and governments to develop programs and services that improve access to care.
Conference Location: Crowne Plaza Seattle Downtown, 1113 6th Ave, Seattle, Washington, United States Of America
Conference Dates: April 27th to 28th 2019
The 2019 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer care. The summit will feature lectures, discussions and presidential-style debates among leaders across the spectrum of healthcare delivery. It is our hope that this summit will lead us in a direction to help thousands of cancer patients and their families who are still deprived of cutting-edge cancer treatment.
- Physicians, Nurses, Pharmacists
- Healthcare & Industry executives
- Non-profit leaders
- Government representatives
- Patient advocates, and
- Others interested in cancer care
Larry King joins SCHD19 as debate moderator
The 2019 Summit on National & Global Cancer Health Disparities will feature two debates moderated by Larry King. The debates will cover the topics “Improving Access to Care: #singlepayer versus #multipayer healthcare” and “Reform in #FDA drug approval process: Is it desirable?”
Nationally renowned oncologists to chair Seattle cancer disparities conference, SCHD19
The 2019 Summit on National and Global Cancer Health Disparities will be chaired by Dr. Gary Lyman, Co-Director of the Hutchinson Institute for Cancer Outcomes Research, and Dr. Julie Gralow, the Director of Breast Medical Oncology at the Seattle Cancer Care Alliance.
Abstract Submission deadline: Monday, Dec. 17, 2018